Increased expression of Erythropoietin receptor in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced Parkinsonian model

Physiological Research

Volumn 59, Issue 2, 2010, Pages 281-287

  Wu, Y ^a   Sun, X ^a   Feng, X ^b   Liu, R ^c   Huang, L ^a   Shang, Y ^a   Liang, Z ^a   Chen, J ^a   Qiao, X ^a   Liu, C ^a   Sun, S ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Sanxia College   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

C57BL 6 mice; EPOR; MPTP; Parkinson disease; Ventral mesencephalon

Indexed keywords

ERYTHROPOIETIN RECEPTOR;

ANIMAL; ARTICLE; BRAIN CORTEX; C57BL MOUSE; CORPUS STRIATUM; DISEASE MODEL; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MOUSE; PARKINSONISM; PHYSIOLOGY; SUBSTANTIA NIGRA; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CEREBRAL CORTEX; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; PARKINSONIAN DISORDERS; RECEPTORS, ERYTHROPOIETIN; SUBSTANTIA NIGRA; UP-REGULATION;

EID: 77953955530     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. ASSARAF MI, DIAZ Z, LIBERMAN A, MILLER WH JR, ARVANITAKIS Z, LI Y, BENNETT DA, SCHIPPER HM: Brain erythropoietin receptor expression in Alzheimer disease and mild cognitive impairment. J Neuropathol Exp Neurol 66: 389-398, 2007.
2. BERNAUDIN M, MARTI HH, ROUSSEL S, DIVOUX D, NOUVELOT A, MACKENZIE ET, PETIT E: A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 19: 643-651, 1999.
3. BRINES ML, GHEZZI P, KEENAN S, AGNELLO D, DE LANEROLLE NC, CERAMI C, ITRI LM, CERAMI A: Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 97: 10526-10531, 2000.
4. CHONG ZZ, LIN SH, KANG JQ, MAIESE K: Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1, 3, and 8. J Neurosci Res 71: 659-669, 2003.
5. CHU K, JUNG KH, LEE ST, KIM JH, KANG KM, KIM HK, LIM JS, PARK HK, KIM M, LEE SK, ROH JK: Erythropoietin reduces epileptogenic processes following status epilepticus. Epilepsia 49: 1723-1732, 2008.
6. CSETE M, RODRIGUEZ L, WILCOX M, CHADALAVADA S: Erythropoietin receptor is expressed on adult rat dopaminergic neurons and erythropoietin is neurotrophic in cultured dopaminergic neuroblasts. Neurosci Lett 359: 124-126, 2004.
7. DEHMER T, LINDENAU J, HAID S, DICHGANS J, SCHULZ JB: Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo. J Neurochem 74: 2213-2216, 2000.
8. EID T, BRINES ML, CERAMI A, SPENCER DD, KIM JH, SCHWEITZER JS, OTTERSEN OP, DE LANEROLLE NC: Increased expression of erythropoietin receptor on blood vessels in the human epileptogenic hippocampus with sclerosis. J Neuropathol Exp Neurol 63: 73-83, 2004.
9. GRASSO G, SFACTERIA A, PASSALACQUA M, MORABITO A, BUEMI M, MACRI B, BRINES ML, TOMASELLO F: Erythropoietin and erythropoietin receptor expression after experimental spinal cord injury encourages therapy by exogenous erythropoietin. Neurosurgery 56: 821-827, 2005.
10. GENC S, KURALAY F, GENC K, AKHISAROGLU M, FADILOGLU S, YORUKOGLU K, FADILOǦLU M, GURE A: Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-treated C57/BL mice via increasing nitric oxide production. Neurosci Lett 298: 139-141, 2001.
11. GENC S, AKHISAROGLU M, KURALAY F, GENC K: Erythropoietin restores glutathione peroxidase activity in 1-methyl-4-phenyl-1, 2, 5, 6-tetrahydropyridine-induced neurotoxicity in C57BL mice and stimulates murine astroglial glutathione peroxidase production in vitro. Neurosci Lett 321: 73-76, 2002.
12. HAYLEY S, CROCKER SJ, SMITH PD, SHREE T, JACKSON-LEWIS V, PRZEDBORSKI S, MOUNT M, SLACK R, ANISMAN H, PARK DS: Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. J Neurosci 24: 2045-2053, 2004.
13. HEIKKILA RE, HESS A, DUVOISIN RC: Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Science 225: 1451-1453, 1984.
14. JACKSON-LEWIS V, PRZEDBORSKI S: Protocol for the MPTP mouse model of Parkinson's disease. Nat Protoc 2: 141-151, 2007.
15. JUNK AK, MAMMIS A, SAVITZ SI, SINGH M, ROTH S, MALHOTRA S, ROSENBAUM PS, CERAMI A, BRINES M, ROSENBAUM DM: Erythropoietin administration protects retinal neurons from acute ischemiareperfusion injury. Proc Natl Acad Sci USA 99: 10659-10664, 2002.
16. JUUL SE, YACHNIS AT, ROJIANI AM, CHRISTENSEN RD: Immunohistochemical localization of erythropoietin and its receptor in the developing human brain. Pediatr Dev Pathol 2: 148-158, 1999.
17. LANGSTON JW, BALLARD P, TETRUD JW, IRWIN I: Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219: 979-980, 1983.
18. LEWCZUK P, HASSELBLATT M, KAMROWSKI-KRUCK H, HEYER A, UNZICKER C, SIRÉN AL, EHRENREICH H: Survival of hippocampal neurons in culture upon hypoxia: effect of erythropoietin. NeuroReport 11: 3485-3488, 2000.
19. MARTI HH, WENGER RH, RIVAS LA, STRAUMANN U, DIGICAYLIOGLU M, HENN V, YONEKAWA Y, BAUER C, GASSMANN M: Erythropoietin gene expression in human monkey and murine brain. Eur J Neurosci 8: 666-676, 1996.
20. MORISHITA E, MASUDA S, NAGAO M, TASUDA Y, SASAKI R: Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 76: 105-116, 1997.
21. NOGUCHI CT, ASAVARITIKRAI P, TENG R, JIA Y: Role of erythropoietin in the brain. Crit Rev Oncol Hematol 64: 159-171, 2007.
22. PUSKOVIC V, WOLFE D, WECHUCK J, KRISKY D, COLLINS J, GLORIOSO JC, FINK DJ, MATA M: HSV-mediated delivery of erythropoietin restores dopaminergic function in MPTP-treated mice. Mol Ther 14: 710-715, 2006.
23. VILLA P, BIGINI P, MENNINI T, AGNELLO D, LARAGIONE T, CAGNOTTO A, VIVIANI B, MARINOVICH M, CERAMI A, COLEMAN TR, BRINES M, GHEZZI P: Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med 198: 971-975, 2003.
24. SHANG Y, WU Y, YAO S, WANG X, FENG D, YANG W: Protective effect of erythropoietin against ketamineinduced apoptosis in cultured rat cortical neurons: involvement of PI3K/Akt and GSK-3 beta pathway. Apoptosis 12: 2187-2195, 2007.
25. SIREN AL, KNERLICH F, POSER W, GLEITER CH, BRUCK W, EHRENREICH H: Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol 101: 271-276, 2001.
26. SPANDOU E, PAPOUTSOPOULOU S, SOUBASI V, KARKAVELAS G, SIMEONIDOU C, KREMENOPOULOS G, GUIBA-TZIAMPIRI O: Hypoxia-ischemia affects erythropoietin and erythropoietin receptor expression pattern in the neonatal rat brain. Brain Res 1021: 167-172, 2004.
27. WU Y, SHANG Y, SUN S, LIANG H, LIU R: Erythropoietin prevents PC12 cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis via the Akt/GSK-3beta/caspase-3 mediated signaling pathway. Apoptosis 12: 1365-1375, 2007a.
28. WU Y, SHANG Y, SUN S, LIU R: Antioxidant effect of erythropoietin on 1-methyl-4-phenylpyridinium-induced neurotoxicity in PC12 cells. Eur J Pharmacol 14: 47-56, 2007b.